New hope for pancreatic cancer: four-drug combo tested in phase 2 trial
Disease control
Recruiting now
This study tests a combination of two immunotherapy drugs (adebrelimab and chidamide) plus two chemotherapy drugs (gemcitabine and S1) as a first treatment for people with advanced or metastatic pancreatic cancer. The goal is to see if this mix can slow tumor growth and extend su…
Phase: PHASE2 • Sponsor: Liu Xiufeng • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC